Benjamin J. Hindson - Dec 1, 2021 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Signature
/s/ Eric S. Whitaker, as Attorney-in-Fact
Stock symbol
TXG
Transactions as of
Dec 1, 2021
Transactions value $
-$5,538,929
Form type
4
Date filed
12/3/2021, 04:53 PM
Previous filing
Nov 24, 2021
Next filing
Dec 30, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXG Class A Common Stock Options Exercise $18.4K +3.65K +7.8% $5.04* 50.4K Dec 1, 2021 Direct F1
transaction TXG Class A Common Stock Options Exercise $404K +35.2K +69.89% $11.48* 85.6K Dec 1, 2021 Direct F1
transaction TXG Class A Common Stock Options Exercise $208K +2.79K +3.26% $74.58 88.4K Dec 1, 2021 Direct F1
transaction TXG Class A Common Stock Sale -$787K -5.4K -6.11% $145.66 83K Dec 1, 2021 Direct F1, F2
transaction TXG Class A Common Stock Sale -$787K -5.37K -6.47% $146.53 77.7K Dec 1, 2021 Direct F1, F3
transaction TXG Class A Common Stock Sale -$2M -13.6K -17.46% $147.65 64.1K Dec 1, 2021 Direct F1, F4
transaction TXG Class A Common Stock Sale -$1.12M -7.57K -11.81% $148.42 56.5K Dec 1, 2021 Direct F1, F5
transaction TXG Class A Common Stock Sale -$725K -4.85K -8.58% $149.46 51.7K Dec 1, 2021 Direct F1, F6
transaction TXG Class A Common Stock Sale -$274K -1.82K -3.51% $150.66 49.9K Dec 1, 2021 Direct F1, F7
transaction TXG Class A Common Stock Sale -$318K -2.1K -4.21% $151.46 47.8K Dec 1, 2021 Direct F1, F8
transaction TXG Class A Common Stock Sale -$15.2K -100 -0.21% $152.25 47.7K Dec 1, 2021 Direct F1
transaction TXG Class A Common Stock Sale -$108K -700 -1.47% $153.91 47K Dec 1, 2021 Direct F1, F9
transaction TXG Class A Common Stock Sale -$31.1K -200 -0.43% $155.55 46.8K Dec 1, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TXG Stock Option (right to buy) Options Exercise $0 -3.65K -7.17% $0.00 47.2K Dec 1, 2021 Class A Common Stock 3.65K $5.04 Direct F1, F10
transaction TXG Stock Option (right to buy) Options Exercise $0 -35.2K -51.38% $0.00 33.3K Dec 1, 2021 Class A Common Stock 35.2K $11.48 Direct F1, F11
transaction TXG Stock Option (right to buy) Options Exercise $0 -2.79K -2.05% $0.00 133K Dec 1, 2021 Class A Common Stock 2.79K $74.58 Direct F1, F12
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
F2 This transaction was executed in multiple trades at prices ranging from $145.05 to $145.99. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F3 This transaction was executed in multiple trades at prices ranging from $146.095 to $146.98. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F4 This transaction was executed in multiple trades at prices ranging from $147.03 to $147.99. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F5 This transaction was executed in multiple trades at prices ranging from $148.03 to $148.995. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F6 This transaction was executed in multiple trades at prices ranging from $149.065 to $149.995. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F7 This transaction was executed in multiple trades at prices ranging from $150.12 to $151.11. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F8 This transaction was executed in multiple trades at prices ranging from $151.14 to $152.065. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F9 This transaction was executed in multiple trades at prices ranging from $153.665 to $154.08. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F10 This option, originally for 175,000 shares, of which 127,762 shares have been exercised, vested as to 1/48th of the shares on October 1, 2018 and 1/48th of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.
F11 This option, originally for 100,000 shares, of which 66,666 shares have been exercised, vested as to 1/48th of the shares on May 1, 2019 and 1/48th of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.
F12 This option, originally for 136,000 shares, of which 2,788 shares have been exercised, vested as to 1/48th of the shares on May 1, 2020 and 1/48th of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.

Remarks:

Chief Scientific Officer and President